Kairemo KJ - Search Results

1

Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer.

Erselcan T, Kairemo KJ, Wiklund TA, Hernberg M, Blomqvist CP, Tenhunen M, Bergh J, Joensuu H. Erselcan T, et al. Among authors: kairemo kj. Br J Cancer. 2000 Feb;82(4):777-81. doi: 10.1054/bjoc.1999.0998. Br J Cancer. 2000. PMID: 10732745 Free PMC article. Clinical Trial.

2

Imaging of soft-tissue sarcomas with indium-111-labeled monoclonal antimyosin Fab fragments.

Kairemo KJ, Wiklund TA, Liewendahl K, Miettinen M, Heikkonen JJ, Virkkunen PJ, Aronen HJ, Blomqvist CP. Kairemo KJ, et al. J Nucl Med. 1990 Jan;31(1):23-31. J Nucl Med. 1990. PMID: 2295936 Free article.

3

Cardiac myxomas.

Kairemo KJ, Blomqvist CP, Miettinen M. Kairemo KJ, et al. N Engl J Med. 1996 May 23;334(21):1407-8; author reply 1408-9. N Engl J Med. 1996. PMID: 8614441 No abstract available.

4

Oligoradionuclidetherapy using radiolabelled antisense oligodeoxynucleotide phosphorothioates.

Kairemo KJ, Tenhunen M, Jekunen AP. Kairemo KJ, et al. Anticancer Drug Des. 1996 Sep;11(6):439-49. Anticancer Drug Des. 1996. PMID: 8836109

5

Dosimetry of radionuclide therapy using radiophosphonated antisense oligodeoxynucleotide phosphorothioates based on animal pharmacokinetic and tissue distribution data.

Kairemo KJ, Tenhunen M, Jekunen AP. Kairemo KJ, et al. Antisense Nucleic Acid Drug Dev. 1996 Fall;6(3):215-20. doi: 10.1089/oli.1.1996.6.215. Antisense Nucleic Acid Drug Dev. 1996. PMID: 8915506

6

Biokinetics of indium-111-bleomycin complex in head and neck cancer--implementations for radiochemotherapy.

Kairemo KJ, Ramsay HA, Paavonen TK, Jääskelä-Saari HA, Tagesson M, Ljunggren K, Strand SE. Kairemo KJ, et al. Cancer Detect Prev. 1997;21(1):83-90. Cancer Detect Prev. 1997. PMID: 9043768 Clinical Trial.

7

The effect of three dimensional activity distribution on the dose planning of radioimmunotherapy for patients with advanced intraperitoneal pseudomyxoma.

Laitinen JO, Kairemo KJ, Jekunen AP, Korppi-Tommola T, Tenhunen M. Laitinen JO, et al. Among authors: kairemo kj. Cancer. 1997 Dec 15;80(12 Suppl):2545-52. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2545::aid-cncr29>3.3.co;2-t. Cancer. 1997. PMID: 9406708

8

Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.

Kairemo KJ, Tenhunen M, Jekunen AP. Kairemo KJ, et al. Cancer Gene Ther. 1998 Nov-Dec;5(6):408-12. Cancer Gene Ther. 1998. PMID: 9917096

9

The use of TL detectors in dosimetry of systemic radiation therapy.

Aschan AC, Toivonen MJ, Lampinen JS, Tenhunen M, Kairemo KJ, Korppi-Tommola ET, Jekunen AP, Sipilä P, Savolainen SE. Aschan AC, et al. Among authors: kairemo kj. Acta Oncol. 1999;38(2):189-96. doi: 10.1080/028418699431609. Acta Oncol. 1999. PMID: 10227440

10

Problems associated with oligonucleotide radiotherapy.

Kairemo KJ, Jekunen AP, Tenhunen M. Kairemo KJ, et al. J Nucl Med. 1999 Sep;40(9):1582. J Nucl Med. 1999. PMID: 10492382 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters